Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
- 1 July 2016
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 14 (7) , 973-979
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U54-LM008748)
- American Gastroenterological Association (K08 AR060257, K23 DK097142)
This publication has 51 references indexed in Scilit:
- Colonoscopy Is Associated With a Reduced Risk for Colon Cancer and Mortality in Patients With Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology, 2015
- Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysisClinical Gastroenterology and Hepatology, 2014
- Improving Case Definition of Crohnʼs Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language ProcessingInflammatory Bowel Diseases, 2013
- Intestinal Inflammation Targets Cancer-Inducing Activity of the MicrobiotaScience, 2012
- Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 YearsGastroenterology, 2012
- Risk of colorectal cancer in self‐reported inflammatory bowel disease and modification of risk by statin and NSAID useCancer, 2010
- Colorectal carcinoma and inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2004
- The Risk of Cancer in Users of StatinsJournal of Clinical Oncology, 2004
- Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitisGastroenterology, 2004
- The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut, 2001